Table 1.
Clinical characteristics at baseline
| TTE measurements | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient | Age (years) | Gender | BMI (kg/m2) | Comorbidities | NYHA class | STS score (%) | AVA (cm2) | PGmean (mm Hg) | V max (m/s) | LVEF (%) | AR grade (0–3) |
| 1 | 81 | F | 17.1 | PH, CKD | IV | 17.35 | 0.36 | 47 | 4.49 | 20 | 0 |
| 2 | 67 | M | 26.9 | DM, HTN, Af, COPD | IV | 8.61 | 0.65 | 50 | 4.69 | 54 | 1 |
| 3 | 77 | M | 19.3 | HTN, COPD, CKD | IV | 12.99 | 0.64 | 42 | 4.18 | 20 | 0 |
| 4 | 75 | M | 22.0 | Af, COPD, CKD | III | 4.54 | 0.50 | 32 | 3.90 | 36 | 2 |
| 5 | 80 | M | 21.3 | CKD | II | 4.67 | 0.44 | 46 | 4.37 | 52 | 1 |
| 6 | 71 | F | 23.7 | HTN | IV | 3.69 | 0.77 | 40 | 4.06 | 72 | 2 |
| 7 | 79 | M | 22.4 | DM, HTN | III | 4.53 | 0.67 | 42 | 4.10 | 63 | 0 |
| 8 | 72 | F | 23.1 | Anemia | IV | 4.29 | 0.81 | 59 | 5.31 | 41 | 0 |
| 9 | 74 | M | 24.3 | DM, HTN, Prior PCI, PVD, COPD | IV | 7.02 | 0.83 | 41 | 4.50 | 69 | 1 |
| 10 | 77 | M | 24.0 | DM, HTN | III | 5.03 | 0.60 | 43 | 4.40 | 61 | 1 |
| 11 | 81 | F | 16.7 | CKD | II | 6.49 | 0.33 | 77 | 5.93 | 77 | 2 |
| 12 | 72 | M | 24.0 | HTN | III | 3.08 | 0.70 | 46 | 4.50 | 66 | 0 |
Abbreviations: Af, atrial fibrillation; AR, aortic regurgitation; AVA, aortic valve area; PG, pressure gradient; BMI, body mass index; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; HTN, hypertension; LVEF, left ventricle ejection fraction; NYHA, New York Heart Association; PCI, percutaneous coronary intervention; PH, pulmonary hypertension; PVD, peripheral vascular disease; STS, Society of Thoracic Surgeons; TTE, transthoracic echocardiography; V max, maximum velocity.